-
MTBC’s CareCloud Appoints Luma Health as Newest Partner
Post on 1/28/20
-
Outlook Therapeutics Announces Agreements to Streamline Capital Structure
Post on 1/28/20
-
STEALTHbits Enters 2020 With an Expanded Sales Team and Aggressive Growth Plans
Post on 1/28/20
-
FDA Approves Merck's Dificid for Infections in Children
Post on 1/28/20
-
The Vitamin Shoppe Opens New Distribution Channel in Partnership with LA Fitness
Post on 1/27/20
-
electroCore Announces Rebate Agreement with Ascent Health Services
Post on 1/27/20
-
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million
Post on 1/27/20
-
Better Buy: AbbVie vs. Johnson & Johnson
Post on 1/27/20
-
An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences
Post on 1/27/20
-
Applied Therapeutics Announces Upsizing and Pricing of Public Offering of Common Stock
Post on 1/26/20
-
Bristol-Myers Squibb: The Merger Is Complete, Time To Shine
Post on 1/24/20
-
Should Investors Be Worried About Merck's Keytruda?
Post on 1/24/20
-
Pfizer to Market Viagra Through Roman's Telehealth Service
Post on 1/24/20
-
Johnson & Johnson's Fourth-Quarter Results Leave Wall Street With Mixed Emotions
Post on 1/23/20
-
Quest Diagnostics Buys Blueprint Genetics to Help It Read Mountains of DNA Data
Post on 1/23/20
-
MetLife Named to ‘World’s Most Admired Companies’ List by Fortune Magazine
Post on 1/22/20
-
AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer
Post on 1/22/20
-
FDA Puts GlaxoSmithKline's Blood Cancer Drug In the Fast Lane
Post on 1/22/20
-
Merck's Keytruda Could Face Direct Competition from New Chinese Drug
Post on 1/22/20
-
Quest Diagnostics Named One of 2020 "World's Most Admired Companies" by FORTUNE Magazine for Sixth Consecutive Year
Post on 1/21/20
-
Applied Therapeutics Announces Offering of 1,750,000 Shares of Common Stock
Post on 1/21/20
-
Advaxis Prices $10.5M Registered Direct Offering
Post on 1/21/20
-
MTF Biologics Announces Partnership With Net Health Wound Care EMR
Post on 1/21/20
-
Hitachi Chemical Advanced Therapeutics Solutions and Ori Biotech Announce a Joint Development Agreement
Post on 1/21/20
-
OncoHost and RayBiotech Awarded $1 Million Grant From the BIRD Foundation to Advance Precision Oncology for Patients Receiving Immunotherapy
Post on 1/21/20